Skip to main content
Clinical Trials/NL-OMON47608
NL-OMON47608
Completed
Phase 2

Prevention of Cerebral ischaemia in Stent Treatment for Carotid Artery Stenosis - A randomised Multi-centre phase II trial comparing Ticagrelor versus Clopidogrel with outcome assessment on MRI (PRECISE-MRI) - PRECISE-MRI

niversitätsspital Basel (USB), Departement of Neurology and Stroke Center0 sites4 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
carotid narrowing
Sponsor
niversitätsspital Basel (USB), Departement of Neurology and Stroke Center
Enrollment
4
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
April 1, 2022
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversitätsspital Basel (USB), Departement of Neurology and Stroke Center

Eligibility Criteria

Inclusion Criteria

  • Patients with symptomatic or asymptomatic atherosclerotic carotid stenosis
  • (\*50% narrowing of the lumen) in whom revascularisation of the stenosis by CAS
  • is planned routinely are eligible to participate in the study.

Exclusion Criteria

  • Contraindication against use of ASA (acetylsalicylic acid), clopidogrel, or
  • ticagrelor; anticoagulation; thrombolysis within the previous 24 hours; unable
  • to walk unassisted (modified Rankin Scale \>3\); clinically unstable; acute
  • coronary syndrome; need for any cardio\-vascular surgery or intervention, or
  • need for any other invasive procedure requiring halting of Study Medication
  • during the Study, other than the index CAS procedure for which the patient was
  • randomised; bradycardia; dyspnoea; contraindications against MRI
  • (claustrophobia, metal implants, cardiac pacemaker); or participation in
  • another intervention trial. No so\-ccalled vulnerable patients will be included.

Outcomes

Primary Outcomes

Not specified

Similar Trials